Lundbeck Gets EU Antitrust Complaint on Citalopram Deals – Bloomberg
Lundbeck A/S (LUN), the Nordic region’s second-largest drugmaker, was sent a formal antitrust complaint by European Union ... believe its practice has violated European competition law,” the Copenhagen-based company said in a statement.
Subscribe to LegalLaw247.Com Newsletter